Krka d d : Information regarding estimated operating results of the Krka Group for the first half of 2022
July 07, 2022 at 12:44 pm
Share
INI-475/22
KRKA, d. d., Novo mesto
Information regarding estimated operating results of the Krka Group for the first half of 2022
Based on Article 17 of Regulation (EU) no. 596/2014 company Krka, d. d., Novo mesto releases information regarding estimated operating results of the Krka Group for the first half of 2022.
See attached document.
The notice will be published on the Company's website (www.krka.biz) from 7 July 2022 onwards, for a period of at least 5 years.
Krka, d. d., Novo mesto
Date: 07.07.2022
Attachments:Estimated Operating Results for the First Half of 2022
Attachments
Original Link
Original Document
Permalink
Disclaimer
KRKA dd published this content on 07 July 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 07 July 2022 11:43:01 UTC.
Krka dd Novo Mesto is a Slovenia-based company engaged in the production of pharmaceutical preparations. The Company operates through four segments: Prescription Pharmaceuticals that includes medicines for the treatment of cardiovascular diseases, alimentary tract and metabolism and drugs for diseases of the central nervous system, among others; Non-prescription Products, providing vitamins and minerals, cough and cold products, analgesics, sore throat products, among others; Animal Health Products, which offers general anti-infectives and antiparasitics for animals; Health Resort and Tourist Services consisting of Spa resorts in Smarjeske Toplice, Dolenjske Toplice, Strunjan, Novo Mesto and Otocec. Krka dd Novo Mesto is a controlling company of the Krka Group that includes two subsidiaries in Slovenia, Terme Krka doo and Farma GRS doo, and over 20 subsidiaries abroad in such countries as Croatia, Germany, Sweden, Poland, Spain, United States, Ireland, among others.
KRKA, D. D. 
